What we're reading, May 10, 2016: the FDA is looking to redefine "healthy"; leadership at the National Institutes of Health Clinical Center is getting overhauled; and Senator Bernie Sanders' tax and spending proposals would add $18 trillion to the federal deficit.
The FDA is looking to redefine “healthy” in light of new research on nutrition. The agency will seek comments from the public and food experts on what the modern definition of healthy should be, reported The Wall Street Journal. The term was first officially defined in 1994. The process is expected to take years to complete. Part of the change is related to a recent petition from Kind LLC, which makes fruit-and-nut bars but was sent a warning letter for using the term “healthy” on packaging. Food can only be marketed as such if it meets 5 criteria related to the levels of fat, saturated fat, sodium, cholesterol, and beneficial nutrients.
Leadership at the National Institutes of Health (NIH) Clinical Center is getting overhauled. According to The Washington Post, a review of the hospital found that research interests had taken priority over patient safety. The hospital leadership will be replaced with a new team experienced in patient safety and the director of the NIH wants the positions of chief executive, chief operating officer, and chief medical officer to all be filled by physicians. The hospital review was the first in decades.
Senator Bernie Sanders’ tax and spending proposals would create add $18 trillion to the federal deficit. The Associated Press reported that the presidential hopeful’s proposal to raise taxes mostly on upper-income earners by more than $15 trillion over 10 years still wouldn’t cover the cost of his Medicare for All healthcare plan, which is more than $30 trillion. Sanders’ campaign has claimed the analysis from the Urban-Brookings Tax Policy Center and the Urban Institute Health Policy Center overestimates the cost of the healthcare proposal and underestimates the healthcare savings the country would reap.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More